Quantcast
Viewing all articles
Browse latest Browse all 3020

Revance weighs competing buyout offer amid push from original bidder

Revance Therapeutics said Wednesday it will have talks with Teoxane on its bid to take over Revance's company. But Crown Laboratories — the initial bidder — has made clear it won't wait much longer on its own ...

Viewing all articles
Browse latest Browse all 3020

Trending Articles